Join
Live feed
·
PRReleasevia Quantisnow
Innoviva Inc. logo

Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea

ByQuantisnow·Wall Street's wire, on your screen.
INVA· Innoviva Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INVA (Innoviva Inc.) and more on Quantisnow.